Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Zuber

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Genes & Development|November 16, 2017
Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescenceMarieke Aarts, Athena Georgilis, Meryam Beniazza, et al.
Oncotarget|February 1, 2018
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromesAnna Palau, Anne-Kathrin Garz, Jeannine Diesch, et al.
Blood|September 12, 2022
EVI1 drives leukemogenesis through aberrant ERG activationJohannes Schmoellerl, Inês A M Barbosa, Martina Minnich, et al.
Nature Communications|September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemiaJessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.
Genes & Development|April 3, 2009
Mouse models of human AML accurately predict chemotherapy responseJohannes Zuber, Ina Radtke, Timothy S Pardee, et al.
Blood|November 2, 2014
Preclinical efficacy of MEK inhibition in Nras-mutant AMLMichael R Burgess, Eugene Hwang, Ari J Firestone, et al.
Nature Biotechnology|July 29, 2020
Isolating live cell clones from barcoded populations using CRISPRa-inducible reportersChristian Umkehrer, Felix Holstein, Laura Formenti, et al.
Elife|August 25, 2023
SPOP targets the immune transcription factor IRF1 for proteasomal degradationIrene Schwartz, Milica Vunjak, Valentina Budroni, et al.
Scientific Reports|July 2, 2025
Engineered microRNA scaffolds for potent gene silencing in vivoGiuseppe Militello, Alyssa Greig, Chongfeng Bi, et al.
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Genes & Development|November 16, 2017
Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescenceMarieke Aarts, Athena Georgilis, Meryam Beniazza, et al.
Oncotarget|February 1, 2018
Polycomb protein RING1A limits hematopoietic differentiation in myelodysplastic syndromesAnna Palau, Anne-Kathrin Garz, Jeannine Diesch, et al.
Blood|September 12, 2022
EVI1 drives leukemogenesis through aberrant ERG activationJohannes Schmoellerl, Inês A M Barbosa, Martina Minnich, et al.
Nature Communications|September 19, 2023
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemiaJessica Ebner, Johannes Schmoellerl, Martin Piontek, et al.
Genes & Development|April 3, 2009
Mouse models of human AML accurately predict chemotherapy responseJohannes Zuber, Ina Radtke, Timothy S Pardee, et al.
Blood|November 2, 2014
Preclinical efficacy of MEK inhibition in Nras-mutant AMLMichael R Burgess, Eugene Hwang, Ari J Firestone, et al.
Nature Biotechnology|July 29, 2020
Isolating live cell clones from barcoded populations using CRISPRa-inducible reportersChristian Umkehrer, Felix Holstein, Laura Formenti, et al.
Elife|August 25, 2023
SPOP targets the immune transcription factor IRF1 for proteasomal degradationIrene Schwartz, Milica Vunjak, Valentina Budroni, et al.
Scientific Reports|July 2, 2025
Engineered microRNA scaffolds for potent gene silencing in vivoGiuseppe Militello, Alyssa Greig, Chongfeng Bi, et al.
Cancer Discovery|August 8, 2014
Development of siRNA payloads to target KRAS-mutant cancerTina L Yuan, Christof Fellmann, Chih-Shia Lee, et al.
Pageof 17